About
Technology
Issues
FAQ
Links
Official Page
An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.